Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

Title
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
Authors
Keywords
Computed axial tomography, B cells, Myositis, Muscle analysis, Methotrexate, Adverse events, Immunosuppressives, Drug therapy
Journal
PLoS One
Volume 10, Issue 11, Pages e0133702
Publisher
Public Library of Science (PLoS)
Online
2015-11-06
DOI
10.1371/journal.pone.0133702

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started